Instructions for
Authors
ONLINE MANUSCRIPT SUBMISSION:
An online submission and tracking service via Internet
facilitates a speedy and cost-effective submission of manuscripts.
The full manuscript has to be submitted online via
Bentham's Journal Content Management System (CMS) at (http://bsp-cms.eurekaselect.com/index.php/CNR/)
View
Submission Instructions
Manuscripts must be submitted by one of the authors of the
manuscript, and should not be submitted by anyone on their
behalf. The principal/corresponding author will be required
to submit a Covering Letter along with the manuscript, on
behalf of all the co-authors (if any). The author(s) will
confirm that the manuscript (or any part of it) has not been
published previously or is not under consideration for publication
elsewhere. Furthermore, any illustration, structure or table
that has been published elsewhere must be reported, and copyright
permission for reproduction must be obtained.
For all online submissions, please provide soft copies of
all the materials (main text in MS Word or Tex/LaTeX), figures
/ illustrations in TIFF, PDF or JPEG, and chemical structures
drawn in ChemDraw (CDX) / ISISDraw (TGF) as separate files,
while a PDF version of the entire manuscript must also be
included, embedded with all the figures / illustrations /
tables / chemical structures etc. It is advisable that the
document files related to a manuscript submission should always
have the name of the corresponding author as part of the file
name, i.e., “Cilli MS text.doc”, “Cilli
MS Figure 1”, etc.
It is imperative that before submission, authors should carefully
proofread the files for special characters, mathematical symbols,
Greek letters, equations, tables references and images, to
ensure that they appear in proper format. References, figures,
tables, structures, etc. should be refered in the text at
the places where they are discussed first. Figure legends/captions
should also provided.
A successful electronic submission of a manuscript will be
followed by a system-generated acknowledgement to the principal/corresponding
author. Any queries therein should be addressed to ambreenirshad@benthamscience.org
MANUSCRIPTS PUBLISHED: The
Journal publishes peer-reviewed full-length review articles,
research papers and drug clinical trial studies written in
English. Single topic/thematic issues may also be considered
for publication.
Single Topic Issues: These special issues
are peer-reviewed and may contain invited or uninvited review
articles or a mixture of research articles, reviews and drug
clinical trials. The Special Editor will offer a short perspective
and co-ordinate the solicitation of about 10 to 13 manuscripts
from leading scientists, with a total page limit ranging between
100 to 150 printed journal pages. Each printed journal page
is on average 900 words (excluding any figures, plates and
diagrams). Authors interested in editing a single topic issue
in an emerging topic of drug design and discovery may submit
their proposal to the Editor-in-Chief at cnr@benthamscience.org
for consideration.
MANUSCRIPT LENGTH:
Research Articles: Research articles should be 4000-8000
words excluding figures, structures, photographs, schemes,
tables etc.
Full-Length Reviews: Full-length reviews
should be 8000-40000 words excluding figures, structures,
photographs, schemes, tables etc.
Randomized Drug Clinical Trial Studies: Trial
studies should be 1500 to 40000 words excluding figures, structures,
photographs, schemes, tables etc.
There is no restriction on the number of figures, tables or
additional files e.g. video clips, animation and datasets,
that can be included with each article online. Authors should
include all relevant supporting data with each article (Refer
to Supplementary Material section).
MANUSCRIPT PREPARATION:
The manuscript should be written in English in a clear, direct
and active style. All pages must be numbered sequentially,
facilitating in the reviewing and editing of the manuscript.
For further convenience, our contracted service provider Eureka
Science can provide assistance to authors for the preparation
of manuscripts.
MANUSCRIPT SECTIONS FOR PAPERS: Manuscripts
may be divided into the following sections:
Covering letter
Title
Title page
Abstract
Keywords
Text organization
List of abbreviations (if any)
Conflict of interest (if any)
Acknowledgements (if any)
References
Appendices
Figures/illustrations (if any)
Chemical structures (if any)
Table (if any)
Supportive/Supplementary material (if any)
Covering Letter: It is mandatory that a signed
covering letter should also be submitted along with the manuscript
by the author to whom correspondence is to be addressed, delineating
the scope of the submitted article declaring the potential
competing interests, acknowledging contributions from authors
and funding agencies, and certifying that the paper is prepared
according to the 'Instructions for Authors'.
All inconsistencies in the text and in the reference section,
and any typographical errors must be carefully checked and
corrected before the submission of the manuscript. The article
contains no such material or information that may be unlawful,
defamatory, fabricated, plagiarized, or which would, if published,
in any way whatsoever, violate the terms and conditions as
laid down in the copyright agreement. The authors acknowledge
that the publishers have the legal right to take appropriate
action against the authors for any such violation of the terms
and conditions as laid down in the copy right agreement. DOWNLOAD
COVERING LETTER
Title: The title of the article should
be precise and brief and must not be more than 120 characters.
Authors should avoid the use of non-standard abbreviations.
The title must be written in title case except for articles,
conjunctions and prepositions.
Authors should also provide a short ‘running title’.
Title, running title, by line correspondent foot note &
keywords should be written as presented in original manuscript.
Title Page: Title page should include paper
title, author(s) full name and affiliation, corresponding
author(s) names complete affiliation/address, along with phone,
fax and email.
Abstract: The abstract should not exceed 250 words
for review and research papers, and 150 words for letters
and drug clinical trial studies summarizing the essential
features of the article.
Keywords: Provide 6 to 8 keywords in alphabetical
order.
Text Organization: The main text should begin
on a separate page and should be divided into title page,
abstract and the main text. The text may be subdivided further
according to the areas to be discussed, which should be followed
by the Acknowledgement, List of Abbreviations, Conflict of
Interest (if any) and Reference sections. For review, the
manuscript should be divided into title page, abstract and
the main text. The text may be subdivided further according
to the areas to be discussed, which should be followed by
the Acknowledgement (if any) and Reference sections. For Research
Articles the manuscript should begin with the title page and
abstract followed by the main text, which must be structured
into separate sections as Introduction, Material and
Methods, Results, Discussion, Conclusion, Trial Registration,
Acknowledgements and References.
The Review Article should mention any previous important recent
and old reviews in the field and contain a comprehensive discussion
starting with the general background of the field. It should
then go on to discuss the salient features of recent developments.
The authors should avoid presenting material which has already
been published in a previous review. The authors are advised
to present and discuss their observations in brief. The manuscript
style must be uniform throughout the text and 10 pt Times
New Roman fonts should be used. The full term for an abbreviation
should precede its first appearance in the text unless it
is a standard unit of measurement. The reference numbers should
be given in square brackets in the text. Italics should be
used for Binomial names of organisms (Genus and Species),
for emphasis and for unfamiliar words or phrases. Non-assimilated
words from Latin or other languages should also be italicized
e.g. per se, et al. etc.
Standard Protocol on Approvals, Registrations, Patient
Consents & Animal Protection: All clinical
investigations must be conducted according to the Declaration
of Helsinki principles. Authors must comply with the guidelines
of the International Committee of Medical Journal Editors
(http://www.icmje.org)
with regard to the patient’s consent for research or
participation in a study. Patients' names, initials, or hospital
numbers must not be mentioned anywhere in the manuscript (including
figures). Editors may request that authors provide documentation
of the formal review and recommendation from the institutional
review board or ethics committee responsible for oversight
of the study.
In addition to the standard patient consent for participation
in research, authors are responsible for obtaining patient
consent-to-disclose forms for all recognizable patients in
photographs, videos, or other information that may be published
in the Journal, in derivative works, or on the journal’s
web site and providing the manuscript to the recognizable
patient for review before submission. The consent-to-disclose
form should indicate specific use (publication in the medical
literature in print and online, with the understanding that
patients and the public will have access) of the patient's
information and any images in figures or videos, and must
contain the patient's signature or that of a legal guardian
along with a statement that the patient or legal guardian
has been offered the opportunity to review the identifying
materials and the accompanying manuscript.
For research involving animals, the authors should indicate
whether the procedures followed were in accordance with the
standards set forth in the Guide for the Care and Use of Laboratory
Animals (published by the National Academy of Science, National
Academy Press, Washington, D.C.).
A specific declaration of such approval and consent-to-disclose
form must be made in the cover letter and in a stand-alone
paragraph at the end of the Methods section especially in
the case of human studies where inclusion of a statement regarding
obtaining the written informed consent from each subject or
subject's guardian is a must. The original should be retained
by the guarantor or corresponding author. Editors may request
to provide the original forms by fax or email.
Randomized Drug Clinical Trial Studies: Randomized
Drug clinical trial studies are biomedical or health-related
interventional and/or observational research studies conducted
in phases in human beings who will be randomly allocated to
receive or not receive a preventive, therapeutic, or diagnostic
intervention that follows a pre-defined protocol. The study
is intended to find out whether promising approaches to the
disease prevention, diagnosis, and treatment are safe and
effective.
All randomized clinical trials should include a flow diagram
and authors should provide a completed randomized trial checklist
(see CONSORT Flow Diagram and Checklist;
http://www.consort-statement.org) and a trial protocol.
Authors of randomized controlled trials are encouraged to
submit trial protocols along with their manuscripts. All clinical
trials must be registered (before recruitment of the first
participant) at an appropriate online public trial registry
that must be independent of for-profit interest. Trial registry
name, registration identification number, and the URL for
the registry should be included at the end of the abstract
and also in the space provided on the online manuscript submission
form. If your research article reports the results of a controlled
health care intervention, list your trial registry, along
with the unique identifying number. Note that there should
be no space between the letters and numbers of your trial
registration number. Studies designed for other purposes,
such as to study pharmacokinetics or major toxicity (e.g.,
phase 1 trials), are exempt.
Each manuscript should clearly state an objective or hypothesis;
the design and methods (including the study setting and dates,
patients or participants with inclusion and exclusion criteria,
or data sources, and how these were selected for the study);
the essential features of any interventions; the main outcome
measures; the main results of the study; a comment section
placing the results in context with the published literature
and addressing study limitations; and the conclusions. Data
included in research reports must be original.
Greek Symbols and Special Characters:
Greek symbols and special characters often undergo formatting
changes and get corrupted or lost during preparation of manuscript
for publication. To ensure that all special characters used
are embedded in the text, these special characters should
be inserted as a symbol but should not be a result of any
format styling (Symbol font face) otherwise they will be lost
during conversion to PDF/XML.
Authors are encouraged to consult reporting guidelines. These
guidelines provide a set of recommendations comprising a list
of items relevant to their specific research design. Chemical
equations, chemical names, mathematical usage, unit of measurements,
chemical and physical quantity & units must conform to
SI and Chemical Abstracts or IUPAC.
All kinds of measurements should be reported only in International
System of Units (SI).
List of Abbreviations: If abbreviations
are used in the text either they should be defined in the
text where first used, or a list of abbreviations can be provided.
Conflict of Interest: Financial contributions
to the work being reported must be clearly acknowledged, as
should any potential conflict of interest under the heading
‘Conflict of Interest’. Authors must list the
source(s) of funding for the study, for each author, and for
the manuscript preparation.
Acknowledgements: All individuals listed
as authors must have contributed substantially to the design,
performance, analysis, or reporting of the work and are required
to indicate their specific contribution. Anyone (individual/company/institution)
who has substantially contributed to the study for important
intellectual content, or who was involved in the article’s
drafting the manuscript or revising must also be acknowledged.
Guest or honorary authorship based solely on position (e.g.
research supervisor, departmental head) is discouraged.
The specific requirements for authorship have been defined
by the International Committee of Medical Journal Editors
(ICMJE; http://www.icmje.org).
Examples of authors' contributions are: 'designed research/study',
'performed research/study', 'contributed important reagents',
'collected data', 'analyzed data', 'wrote paper' etc. This
information must be included in the submitted manuscript as
a separate paragraph under the heading ‘Acknowledgements’.
The corresponding author is responsible for obtaining permission
from all co-authors for the submission of any version of the
manuscript and for any changes in the authorship.
References: References must be listed in
the numerical system (Vancouver). All references should be
numbered sequentially [in square brackets] in the text and
listed in the same numerical order in the reference section.
The reference numbers must be finalized and the bibliography
must be fully formatted before submission.
See below examples of references listed in the Vancouver style:
Standard Journal Reference
If the number of authors exceeds six then et al.
will be used after three names (the term “et al.”
should be in italics.)”
[1] Cortright DN, Szallasi A. TRP channels and pain. Curr
Pharm Des 2009; 15(15): 1736-49.
[2] Shahrestani P, Mueller LD, Rose MR. Does aging stop? Curr
Aging Sci 2009; 2(1): 3-11.
More than Six Authors
[3] Frankel AE, Zuckero SL, Mankin AA, et al. Anti-CD3
recombinant diphtheria immunotoxin therapy of cutaneous T
cell lymphoma. Curr Drug Targets 2009;10(2): 104-9.
Edited Book
[4] Blaxter PS, Farnsworth TP. Social health and class inequalities.
In: Carter C, Peel JR, Eds. Equalities and inequalities in
health. 2nd ed. London: Academic
Press 1976; pp. 165-78.
Chapter in a Book
[5] Phillips SJ, Whisnant JP. Hypertension and
stroke. In: Laragh JH, Brenner BM, Eds. Hypertension: pathophysiology,
diagnosis, and management. 2nd ed. New York: Raven Press 1995;
pp. 465-78.
Patent
[6] Larsen CE, Trip R, Johnson CR. Methods for
procedures related to the electrophysiology of the heart.
US Patent 5529067, 1995.
Conference Proceedings
[7] Kimura J, Shibasaki H, Eds. Recent advances
in clinical neurophysiology. Proceedings of the 10th International
Congress of EMG and Clinical Neurophysiology; 1995 Oct 15-19;
Kyoto, Japan. Amsterdam: Elsevier 1996.
Thesis and Dissertation
[8] Borkowski MM. Infant sleep and feeding:
a telephone survey of Hispanic Americans. PhD dissertation.
Mount Pleasant (MI): Central Micihigan University 2002.
Electronic Material
Journal Article in Electronic Format
[9] Frangioni G, Bianchi S, Fuzzi G, Borgioli G. Dynamics
of hepatic melanogenesis in newts in recovery phase from hypoxia.
Open Zoo J 2009; 2: 1-7. Available from: http://www.benthamscience.com/open/tozj/openaccess2.htm
[cited: 26th Jan 2009].
[10] Abood S. Quality improvement initiative in nursing homes:
the ANA acts in an advisory role. Am J Nurs [serial on the
Internet]. June 2002 [cited: 12th
Aug 2002]; 102(6): [about 3 p.]. Available from: http://www.nursingworld.org/AJN/2002/june/Wawatch.htm
Some important points to remember:
• All references must be complete and accurate.
• Online citations should include the date of access.
• Journal titles should conform to the present ACM Guide
to Computing Literature/Chemical Abstracts etc. abbreviations.
• If the number of authors exceeds six then et al.
will be used after three names (the term “et al.”
should be in italics).
• Special care should be taken of the punctuation convention
as described in the above-mentioned examples.
• Avoid using superscript in the in-text citations and
reference section.
• Abstracts, unpublished data and personal communications
(which can only be included if prior permission has been obtained)
should not be given in the reference section but they may
be mentioned in the text and details provided as footnotes.
• The authors are encouraged to use a recent version
of EndNote (version 5 and above) or Reference Manager (version
10) when formatting their reference list, as this allows references
to be automatically extracted.
Appendices: In case there is a need to present
lengthy, but essential methodological details, appendices
must be used, which can be a part of the article. An appendix
must not exceed three pages (Times New Roman, 12 point fonts,
900 max. words per page).The information should be provided
in a condensed form, ruling out the need of full sentences.
A single appendix should be titled APPENDIX, while more than
one can be titled APPENDIX A, APPENDIX B, and so on.
Figures/ Illustrations (if any):
All authors must strictly follow the guidelines below for
preparing illustrations for publication in Current
Neurovascular Research. If the figures are found
to be sub-standard, then the manuscripts will be rejected/
and the authors offered the option of figure improvement professionally
by Bentham Publishing Services.
The costs for such improvement will be charged to the authors.
The authors should provide the illustrations as separate files,
as well as embedded in the text file, numbered consecutively
in the order of their appearance. Each figure should include
a single illustration. Each figure should be closely cropped
to minimize the amount of white space surrounding the illustration.
If a figure consists of separate parts, it is important that
a single composite illustration file be submitted, containing
all parts of the figure.
Photographs should be provided with a scale bar if appropriate,
as well as high-resolution component files.
Scaling/Resolution:
For Line Art image type, which is generally an image based
on lines and text and does not contain tonal or shaded areas,
the preferred file format is TIFF or EPS, with color mode
being Monochrome 1-bit or RGB, in a resolution of 900-1200
dpi.
For Halftone image type, which is generally a continuous
tone photograph and contains no text, the preferred file format
is TIFF, with color mode being RGB or Grayscale, in a resolution
of 300 dpi.
For Combination image type, which is generally an image containing
halftone in addition to text or line art elements, the preferred
file format is TIFF, with color mode being RGB or Grayscale,
in a resolution of 500-900 dpi.
Formats:
• Illustrator
• EPS (preferred format for diagrams)
• PDF (also especially suitable for
diagrams)
• PNG (preferred format for photos
or images)
• Microsoft Word (version 5 and above;
figures must be a single page)
• PowerPoint (figures must be a single
page)
• TIFF
• JPEG (conversion should be done using
the original file)
• BMP
• CDX (ChemDraw)
• TGF (ISISDraw)
Bentham Science Publishers does not process figures submitted
in GIF format.
If the large size of TIFF or EPS figures acts as an obstacle
to online submission, authors may find that conversion to
JPEG format before submission results in significantly reduced
file size and upload time, while retaining acceptable quality.
JPEG is a 'lossy' format. However, in order to maintain acceptable
image quality, it is recommended that JPEG files are saved
at High or Maximum quality.
Files should not be compressed with tools such as Zipit or
Stuffit prior to submission as these tools will in any case
produce negligible file-size savings for JPEGs and TIFFs,
which are already compressed.
Please do not:
1. Supply embedded graphics in your word processor (spreadsheet,
presentation) document;
2. Supply files that are optimized for screen use (like GIF,
BMP, PICT, WPG); the resolution is too low;
3. Supply files that are too low in resolution;
4. Submit graphics that are disproportionately large for the
content.
Image Conversion Tools:
There are many software packages, many of them freeware or
shareware, capable of converting to and from different graphics
formats, including PNG.
Good general tools for image conversion include GraphicConverter
on the Macintosh, PaintShop Pro, for Windows, and ImageMagick,
which is available on Macintosh, Windows and UNIX platforms.
Note that bitmap images (e.g. screenshots) should not be converted
to EPS, since this will result in a much larger file size
than the equivalent JPEG, TIFF, PNG or BMP, with no increase
in quality. EPS should only be used for images produced by
vector-drawing applications such as Adobe Illustrator or CorelDraw.
Most vector-drawing applications can be saved in, or exported
as, EPS format. In case the images have been originally prepared
in an Office application, such as Word or PowerPoint, then
the original Office files should be directly uploaded to the
site, instead of being converted to JPEG or another format
that may be of low quality.
Color Figures/Illustrations:
•The cost for the first published page of color figures
is US$ 965; the second additional page will
be for US$ 705 and each subsequent page for
US$ 480.
•Color figures should be supplied in CMYK not RGB colors.
Chemical Structures (if any):
Chemical structures must be prepared in ChemDraw/CDX
and provided as separate file.
Structure Drawing Preferences:
[As according to the ACS style sheet]
Drawing Settings:
Chain angle 120°
Bond spacing 18% of width
Fixed length 14.4
pt (0.500cm, 0.2in)
Bold width
2.0 pt (0.071cm, 0.0278in)
Line width 0.6
pt (0.021cm, 0.0084in)
Margin width 1.6 pt
(0.096cm)
Hash spacing 2.5 pt (0.088cm, 0.0347in)
Text Settings:
Font
Times New Roman
Size
8 pt
Under the Preference Choose:
Units
points
Tolerances 3
pixels
Under Page Setup Use:
Paper
US letter
Scale
100%
Tables (if any):
• Data Tables should be submitted in Microsoft
Word table format.
• Each table should include a title/caption being explanatory
in itself with respect to the details discussed in the table.
Detailed legends may then follow.
• Table number in bold font i.e. Table 1,
should follow a title. The title should be in small case with
the first letter in caps. A full stop should be placed at
the end of the title.
• Tables should be embedded in the text exactly according
to their appropriate placement in the submitted manuscript.
• Columns and rows of data should be made visibly distinct
by ensuring that the borders of each cell are displayed as
black lines.
• Tables should be numbered in Arabic numerals sequentially
in order of their citation in the body of the text.
• If a reference is cited in both the table and text,
please insert a lettered footnote in the table to refer to
the numbered reference in the text.
• Tabular data provided as additional files can be submitted
as an Ms Excel spreadsheet.
Supportive/Supplementary Material (if any):
We do encourage to append supportive material, for example
a PowerPoint file containing a talk about the study, a PowerPoint
file containing additional screenshots, a Word, RTF, or PDF
document showing the original instrument(s) used, a video,
or the original data (SAS/SPSS files, Ms Excel files, Access
Db files etc.) provided it is inevitable or endorsed by the
journal's Editor.
Supportive/Supplementary material intended for publication
must be numbered and referred to in the manuscript but should
not be a part of the submitted paper. In-text citations as
well as a section with the heading "Supportive/Supplementary
Material" before the "References" section should
be provided. Here, all Supportive/Supplementary Material should
be listed and a brief caption line for each file describing
its contents must be included.
Any additional files will be linked into the final published
article in the form supplied by the author, but will not be
displayed within the paper. They will be made available in
exactly the same form as originally provided only on our Web
site. Please also make sure that each additional file is a
single table, figure or movie (please do not upload linked
worksheets or PDF files larger than one sheet). Supportive/
Supplementary material must be provided in a single zipped
file not larger than 4 MB.
Authors must clearly indicate if these files are not for publication
but meant for the reviewers'/editors' perusal only.
PERMISSION FOR REPRODUCTION: For obtaining
permission for reproducing any material published in an article
by Bentham Science Publishers, please fill in the
request FORM
and send to cnr@benthamscience.org
for consideration.
Published/reproduced material should not be included unless
written permission has been obtained from the copyright holder,
which should be forwarded to the Editorial Office in case
of acceptance of the article for publication.
AUTHORS AND INSTITUTIONAL AFFILIATIONS:
The author will be required to provide their full names, the
institutional affiliations and the location, with an asterisk
in front of the name of the principal/corresponding author.
The corresponding author(s) should be designated and their
complete address, business telephone and fax numbers and e-mail
address must be stated to receive correspondence and galley
proofs.
PAGE CHARGES: No page charges will be levied
to authors for the publication of their article.
LANGUAGE AND EDITING: Manuscripts
submitted containing many English typographical errors will
not be published. Manuscripts which are accepted for publication
on condition that the written English submitted is corrected,
will be sent a quote by Eureka
Science, a professional language editing company. Authors
from non-English language countries who have poor English
language written skills, are advised to contact the language
editing company prior to submitting their manuscript to the
journal. Please contact Eureka
Science for a language editing quote at e-mail: info@eureka-science.com
stating the total number of words of the article to be edited.
PROOF CORRECTIONS: Authors will receive
page proofs of their accepted paper before publications. To
avoid delays in publication, proofs should be checked immediately
for typographical errors and returned within 48 hours.
Major changes are not acceptable at the proof stage. If unable
to send corrections within 48 hours due to
some reason, the author(s) must at least send an acknowledgement
on receiving the galley proofs or the article will be published
exactly as received and the publishers will not be responsible
for any error occurring in the published manuscript in this
regard.
The corresponding author will be solely responsible for ensuring
that the revised version of the manuscript incorporating all
the submitted corrections receives the approval of all the
co-authors of the manuscript.
REPRINTS: Each first-named
(corresponding) author will receive electronically five free
e-prints. Reprints may be ordered from the Publisher prior
to publication of the article. First named authors may also
order a personal online subscription of the journal at 50%
off the normal subscription rate by contacting the subscription
department at e-mail: subscriptions@benthamscience.org.
OPEN ACCESS PLUS: Accepted articles can
be published online for free open access for all to view,
Open access publishing provides the maximum dissemination
of the article to the largest audience. Authors must pay for
this service. All corresponding authors will be asked to indicate
whether or not they wish to pay to have their paper made freely
available on publication. If authors do not select the Open
Access option, then their article will be published with standard
subscription-based access at no charge.
Bentham Science Publishers offers authors the choice of open
access publication of their articles at a fee of US$
2,900 per published article which allows indefinite
free-to-view online publication with Bentham Science Publishers.
For more information please contact us at e-mail: openaccess@benthamscience.org.
FEATURED ARTICLE: Authors may opt to publicize
their article(s) published with Bentham Science by highlighting
their title(s) both at the journal's Homepage and the issue
Contents page at a cost of US$ 600.
REVIEWING AND PROMPTNESS OF PUBLICATION:
All papers submitted for publication are immediately
subjected to editorial scrutiny, usually in consultation with
members of the journal Editorial Advisory Board and outside
independent reviewers. Every effort will be made to peer review
submitted papers quickly. Papers which are delayed by authors
in revision for more than 30 days will have to be re-submitted
as a new submission. Papers accepted for publication are typeset
and proofs are dispatched to authors for any corrections prior
to final publication.
QUICK TRACK Publication: For this journal
an optional fast publication fee-based service called QUICK
TRACK is available to authors for their submitted manuscripts.
QUICK TRACK allows online publication within 2 weeks of receipt
of the final approved galley proofs from the authors. Similarly
the manuscript can be published in the next forthcoming PRINT
issue of the journal. The total publication time, from date
of first receipt of manuscript to its online publication is
10 weeks, subject to its acceptance by the referees and modification
(if any) by the authors within one week.
Corresponding authors who opt for QUICK TRACKS will receive
25 free e-print tokens for their manuscripts.
For more information please contact the Editorial Office by
e-mail at cnr@benthamscience.org.
COPYRIGHT: Authors who publish in Bentham
Science Publishers print & online journals will transfer
copyright to their work to Bentham Science Publishers.
Submission of a manuscript to the respective journals implies
that all authors have read and agreed to the content of the
Covering Letter or the Terms and Conditions. It is a condition
of publication that manuscripts submitted to this journal
have not been published and will not be simultaneously submitted
or published elsewhere. Plagiarism is strictly forbidden,
and by submitting the article for publication the authors
agree that the publishers have the legal right to take appropriate
action against the authors, if plagiarism or fabricated information
is discovered. By submitting a manuscript the authors agree
that the copyright of their article is transferred to the
publishers if and when the article is accepted for publication.
Once submitted to the journal, the author will not withdraw
their manuscript at any stage prior to publication.
Plagiarism Prevention: Bentham Science Publishers
uses the iThenticate software to detect instances of overlapping
and similar text in submitted manuscripts. iThenticate software
checks content uploaded by a journal editorial office against
a database of periodicals, the Internet, and a comprehensive
article database. It generates a similarity report, including
the percentage overlap between the uploaded article and published
material. Any instances of content overlap are treated according
to a journal's peer review integrity statement and the policies
recommended by the editorial Committee. You are assured that
the publisher, where you are submitting your manuscript, is
committed to actively combating plagiarism and publishing
original research.
E-PUB AHEAD OF SCHEDULE: Bentham Science
Publishers are pleased to offer electronic publication of
accepted papers prior to scheduled publication. These peer-reviewed
papers can be cited using the date of access and the unique
DOI number. Any final changes in manuscripts will be made
at the time of print publication and will be reflected in
the final electronic version of the issue. Articles ahead
of schedule may be ordered by pay-per-view at the relevant
links by each article stated via the E-Pub
Ahead of Schedule (http://www.benthamscience.com/cnr/E-Pub-Ahead-of-Schedule.htm).
Disclaimer: Articles appearing in E-Pub Ahead-of-Schedule
sections have been peer-reviewed and accepted for publication
in this journal and posted online before scheduled publication.
Articles appearing here may contain statements, opinions,
and information that have errors in facts, figures, or interpretation.
Accordingly, Bentham Science Publishers, the editors and authors
and their respective employees are not responsible or liable
for the use of any such inaccurate or misleading data, opinion
or information contained of articles in the E-Pub Ahead-of-Schedule.
|
